Ursula Krenz

USPTO Granted Patents = 16 (Patent Applications = 11)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 17)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

10 out of 721

Bayer Intellectual Property Gmbh

patents

3 out of 378

Bayer Pharma Aktiengesellschaft

patents

2 out of 132

Seattle Genetics, Inc.

patents

4. 1 out of 54

Bayer Animal Health Gmbh

patents

5. 1 out of 12,160

Bayer Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11357755 - Compounds for controlling arthropods (2022-06-14),

2. 11298367 - Prodrugs of substituted triazole derivatives and uses thereof (2022-04-12),

3. 9586958 - Prodrug derivatives of substituted triazolopyridines (2017-03-07),

4. 9315543 - Tyrosine based linkers for the releasable connection of peptides (2016-04-19),

5. 9187428 - Substituted dicyanopyridines and use thereof (2015-11-17),

6. 9096639 - 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases (2015-08-04),

7. 8987209 - N-carboxyalkyl-auristatin and the use thereof (2015-03-24),

8. 8957017 - Dipeptoid prodrugs and their use (2015-02-17),

9. 8772498 - Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof (2014-07-08),

10. 8741834 - Dipeptoid prodrugs and the use thereof (2014-06-03),

11. 8722629 - Auristatin derivatives and use thereof (2014-05-13),

12. 8703696 - Dipeptoid prodrugs and the use thereof (2014-04-22),

13. 8420825 - Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs (2013-04-16),

14. 8362015 - Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders (2013-01-29),

15. 8334284 - Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders (2012-12-18),

Title: Innovations and Achievements of Ursula Krenz

Introduction

Ursula Krenz is a notable inventor based in Leichlingen, Germany, recognized for her significant contributions to the field of pharmaceutical compounds. With a remarkable total of 16 patents to her name, she has focused on developing innovative solutions for controlling pests and treating diseases.

Latest Patents

Two of her latest patents highlight her expertise and dedication to advancing pharmaceutical science. The first patent, titled "Compounds for controlling arthropods," pertains to novel halogen-substituted compounds and methods for their preparation. These compounds are particularly valuable for managing animal pests, especially insects and arachnids. The second patent, "Prodrugs of substituted triazole derivatives and uses thereof," relates to specific prodrugs designed for the treatment and prevention of renal and cardiovascular diseases. This patent covers a range of complex chemical compounds and their pharmaceutical applications, underlining Krenz's commitment to impactful medical innovation.

Career Highlights

Ursula Krenz has made significant strides in her career through her work at prestigious companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. Her involvement in these organizations has provided her with a platform to develop her inventive ideas into practical applications that benefit society.

Collaborations

Throughout her career, Krenz has collaborated with notable colleagues, including Hans-Georg Lerchen and Barbara Albrecht-Küpper. These partnerships have allowed her to enhance her research and share insights, further enriching the field of pharmaceutical innovation.

Conclusion

Ursula Krenz's work exemplifies the spirit of innovation and dedication to improving healthcare through her inventions. With her impressive portfolio of patents and significant collaborations, she continues to play a vital role in the advancement of pharmaceutical sciences, contributing to the betterment of society through her inventions.

This text is generated by artificial intelligence and may not be accurate.